Towards Healthcare Research & Consulting
Hemato Oncology Testing Market
Updated Date: 03 August 2026   |   Report Code: 5123
[email protected] +1 804-441-9344
Download Sample Order Now

Hemato Oncology Testing Market Size, Demand and Trends Analysis 2035

Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the top focus, making up 40% of the market. PCR technology dominated testing methods with a 45% share, valued for its high accuracy and efficiency.

Last Updated : 03 August 2026 Category: Diagnostics Insight Code: 5123 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Hemato Oncology Testing Market Assessment

  • Overview
  • Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
    • Services
    • Assay Kits
  • Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Leukemia
      • Acute Myeloid Leukemia
      • Acute Lymphocytic Leukemia
      • Other Leukemia
    • Lymphoma
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Other Cancers
  • Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase Chain Reaction (PCR)
    • Immunohistochemistry (IHC)
    • Next-Generation Sequencing (NGS)
    • Cytogenetics (Karyotyping, FISH)
    • Other Technologies
  • Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals
    • Academic & Research Institutes
    • Others
  • Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Hemato Oncology Testing Market Assessment

  • Overview
  • North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
    • Services
    • Assay Kits
  • North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Leukemia
      • Acute Myeloid Leukemia
      • Acute Lymphocytic Leukemia
      • Other Leukemia
    • Lymphoma
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Other Cancers
  • North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase Chain Reaction (PCR)
    • Immunohistochemistry (IHC)
    • Next-Generation Sequencing (NGS)
    • Cytogenetics (Karyotyping, FISH)
    • Other Technologies
  • North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals
    • Academic & Research Institutes
    • Others

Europe Hemato Oncology Testing Market Assessment

  • Overview
  • Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
    • Services
    • Assay Kits
  • Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Leukemia
      • Acute Myeloid Leukemia
      • Acute Lymphocytic Leukemia
      • Other Leukemia
    • Lymphoma
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Other Cancers
  • Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase Chain Reaction (PCR)
    • Immunohistochemistry (IHC)
    • Next-Generation Sequencing (NGS)
    • Cytogenetics (Karyotyping, FISH)
    • Other Technologies
  • Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals
    • Academic & Research Institutes
    • Others

Asia Pacific Hemato Oncology Testing Market Assessment

  • Overview
  • Asia Pacific Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
    • Services
    • Assay Kits
  • Asia Pacific Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Leukemia
      • Acute Myeloid Leukemia
      • Acute Lymphocytic Leukemia
      • Other Leukemia
    • Lymphoma
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Other Cancers
  • Asia Pacific Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase Chain Reaction (PCR)
    • Immunohistochemistry (IHC)
    • Next-Generation Sequencing (NGS)
    • Cytogenetics (Karyotyping, FISH)
    • Other Technologies
  • Asia Pacific  Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals
    • Academic & Research Institutes
    • Others

Latin America Hemato Oncology Testing Market Assessment

  • Overview
  • Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
    • Services
    • Assay Kits
  • Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Leukemia
      • Acute Myeloid Leukemia
      • Acute Lymphocytic Leukemia
      • Other Leukemia
    • Lymphoma
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Other Cancers
  • Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase Chain Reaction (PCR)
    • Immunohistochemistry (IHC)
    • Next-Generation Sequencing (NGS)
    • Cytogenetics (Karyotyping, FISH)
    • Other Technologies
  • Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals
    • Academic & Research Institutes
    • Others

Middle East and Africa Hemato Oncology Testing Market Assessment

  • Overview
  • Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
    • Services
    • Assay Kits
  • Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Leukemia
      • Acute Myeloid Leukemia
      • Acute Lymphocytic Leukemia
      • Other Leukemia
    • Lymphoma
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Other Cancers
  • Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase Chain Reaction (PCR)
    • Immunohistochemistry (IHC)
    • Next-Generation Sequencing (NGS)
    • Cytogenetics (Karyotyping, FISH)
    • Other Technologies
  • Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals
    • Academic & Research Institutes
    • Others

Company Profiles

  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Qiagen N.V.
  • Abbott
  • EntroGen, Inc.
  • Illumina Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Danaher Corporation
  • Beckman Coulter, Inc.

Conclusion & Recommendations

FAQ's

Answer : The hemato-oncology testing market is expected to expand from USD 4 billion in 2025 to USD 12.88 billion by 2035, registering a strong CAGR of 12.4%

Answer : North America dominated the market in 2025, while Asia-Pacific is anticipated to be the fastest-growing region due to rising cancer incidence and expanding healthcare infrastructure.

Answer : Leading players such as Roche, Qiagen, Abbott, Illumina, Thermo Fisher Scientific, Danaher, and Bio-Rad Laboratories are driving innovation and market expansion.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar